BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33616317)

  • 1. Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
    Ji M; Na N; Lin S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
    Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
    J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
    Zhang J; Dong D; Wei Q; Ren L
    BMC Cancer; 2022 Oct; 22(1):1052. PubMed ID: 36207693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of tumor markers SCC-Ag, CEA, and TPA in patients with cervical precancerous lesions.
    Farzaneh F; Shahghassempour S; Noshine B; Arab M; Yaseri M; Rafizadeh M; Alizadeh K
    Asian Pac J Cancer Prev; 2014; 15(9):3911-4. PubMed ID: 24935573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of preoperative serum squamous cell carcinoma antigen (SCC-Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study.
    Guo Q; Zhu J; Wu Y; Wen H; Xia L; Wu X; Ju X
    Eur J Surg Oncol; 2020 Jan; 46(1):131-138. PubMed ID: 31481274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
    Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ
    Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 9. The Level of Squamous Cell Carcinoma Antigen and Lymph Node Metastasis in Locally Advanced Cervical Cancer.
    Lekskul N; Charakorn C; Lertkhachonsuk AA; Rattanasiri S; Israngura Na Ayudhya N
    Asian Pac J Cancer Prev; 2015; 16(11):4719-22. PubMed ID: 26107230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
    Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    Chen P; Jiao L; Ren F; Wang DB
    BMC Cancer; 2020 May; 20(1):423. PubMed ID: 32410650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer.
    Pan L; Cheng J; Zhou M; Yao Z; Zhang Y
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):239-46. PubMed ID: 22102174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.
    Ran C; Sun J; Qu Y; Long N
    World J Surg Oncol; 2021 Dec; 19(1):343. PubMed ID: 34886853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pretreatment SUV
    Shou H; Yasuo Y; Yuan S; Lou H; Ni J
    Int J Gynaecol Obstet; 2021 Jan; 152(1):112-117. PubMed ID: 33141954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I; Zbucka-Krętowska M; Zaręba K; Lubowicka E; Zajkowska M; Szmitkowski M; Gacuta E; Ławicki S
    BMC Cancer; 2019 Apr; 19(1):398. PubMed ID: 31035945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment plasma levels and diagnostic utility of hematopoietic cytokines in cervical cancer or cervical intraepithelial neoplasia patients.
    Ławicki S; Będkowska GE; Gacuta-Szumarska E; Knapp P; Szmitkowski M
    Folia Histochem Cytobiol; 2012 Jul; 50(2):213-9. PubMed ID: 22763962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Squamous Cell Carcinoma Antigen Level and the Clinicopathological Features of Early-Stage Cervical Squamous Cell Carcinoma and the Predictive Value of Squamous Cell Carcinoma Antigen Combined With Computed Tomography Scan for Lymph Node Metastasis.
    Xu D; Wang D; Wang S; Tian Y; Long Z; Ren X
    Int J Gynecol Cancer; 2017 Nov; 27(9):1935-1942. PubMed ID: 28914639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.